Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESWA: Warfarin for PVT prevention after splenectomy in cirrhosis
NCT02238444Phase 4Unknown
- Sponsor
- Yangzhou University
- Start
- Sep 2014
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of warfarin in portal vein thrombosis (PVT), sponsored by Yangzhou University. Status: unknown.
02
Drugs
warfarin
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT02238444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02238444.